BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 37452879)

  • 1. Emerging roles of the cellular prion protein (PrP
    Limone A; Maggisano V; Sarnataro D; Bulotta S
    Cell Mol Life Sci; 2023 Jul; 80(8):207. PubMed ID: 37452879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between PrP(c) and other ligands with the 37-kDa/67-kDa laminin receptor.
    Mbazima V; Da Costa Dias B; Omar A; Jovanovic K; Weiss SF
    Front Biosci (Landmark Ed); 2010 Jun; 15(3):1150-63. PubMed ID: 20515747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
    Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
    J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 37/67 kDa laminin receptor (LR) inhibitor, NSC47924, affects 37/67 kDa LR cell surface localization and interaction with the cellular prion protein.
    Sarnataro D; Pepe A; Altamura G; De Simone I; Pesapane A; Nitsch L; Montuori N; Lavecchia A; Zurzolo C
    Sci Rep; 2016 Apr; 6():24457. PubMed ID: 27071549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of prion protein glycosylation in replication of human prions by protein misfolding cyclic amplification.
    Camacho MV; Telling G; Kong Q; Gambetti P; Notari S
    Lab Invest; 2019 Nov; 99(11):1741-1748. PubMed ID: 31249376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The N-Terminal Polybasic Region of Prion Protein Is Crucial in Prion Pathogenesis Independently of the Octapeptide Repeat Region.
    Das NR; Miyata H; Hara H; Chida J; Uchiyama K; Masujin K; Watanabe H; Kondoh G; Sakaguchi S
    Mol Neurobiol; 2020 Feb; 57(2):1203-1216. PubMed ID: 31707632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease-associated mutations in the prion protein impair laminin-induced process outgrowth and survival.
    Machado CF; Beraldo FH; Santos TG; Bourgeon D; Landemberger MC; Roffé M; Martins VR
    J Biol Chem; 2012 Dec; 287(52):43777-88. PubMed ID: 23132868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virus Infection, Genetic Mutations, and Prion Infection in Prion Protein Conversion.
    Hara H; Sakaguchi S
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the histo-molecular pathology of human prion disease.
    Baiardi S; Rossi M; Capellari S; Parchi P
    Brain Pathol; 2019 Mar; 29(2):278-300. PubMed ID: 30588685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The first non-prion pathogen identified: neurotropic influenza virus.
    Sakaguchi S; Hara H
    Prion; 2022 Dec; 16(1):1-6. PubMed ID: 34978525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Prion Neuroinvasion Occurs Independently of PrP
    Marshall A; Bradford BM; Clarke AR; Manson JC; Mabbott NA
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Fluorescent Oligothiophene-Bis-Triazine ligand interacts with PrP fibrils and detects SDS-resistant oligomers in human prion diseases.
    Imberdis T; Ayrolles-Torro A; Duarte Rodrigues A; Torrent J; Alvarez-Martinez MT; Kovacs GG; Verdier JM; Robitzer M; Perrier V
    Mol Neurodegener; 2016 Jan; 11():11. PubMed ID: 26809712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and functions of cellular prion proteins in immunocytes.
    Zhang B; Shen P; Yin X; Dai Y; Ding M; Cui L
    Scand J Immunol; 2020 Mar; 91(3):e12854. PubMed ID: 31785109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation of infectivity from seeding ability in prions with alternate docking mechanism.
    Miller MB; Geoghegan JC; Supattapone S
    PLoS Pathog; 2011 Jul; 7(7):e1002128. PubMed ID: 21779169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein.
    Gauczynski S; Peyrin JM; Haïk S; Leucht C; Hundt C; Rieger R; Krasemann S; Deslys JP; Dormont D; Lasmézas CI; Weiss S
    EMBO J; 2001 Nov; 20(21):5863-75. PubMed ID: 11689427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide identification of microRNAs regulating the human prion protein.
    Pease D; Scheckel C; Schaper E; Eckhardt V; Emmenegger M; Xenarios I; Aguzzi A
    Brain Pathol; 2019 Mar; 29(2):232-244. PubMed ID: 30451334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small is not beautiful: antagonizing functions for the prion protein PrP(C) and its homologue Dpl.
    Behrens A; Aguzzi A
    Trends Neurosci; 2002 Mar; 25(3):150-4. PubMed ID: 11852147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The function of the cellular prion protein in health and disease.
    Watts JC; Bourkas MEC; Arshad H
    Acta Neuropathol; 2018 Feb; 135(2):159-178. PubMed ID: 29151170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse prion protein (PrP) segment 100 to 104 regulates conversion of PrP(C) to PrP(Sc) in prion-infected neuroblastoma cells.
    Hara H; Okemoto-Nakamura Y; Shinkai-Ouchi F; Hanada K; Yamakawa Y; Hagiwara K
    J Virol; 2012 May; 86(10):5626-36. PubMed ID: 22398286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of Amyloid β Oligomer Binding to Neurons and Neurotoxicity by the Prion Protein-mGluR5 Complex.
    Beraldo FH; Ostapchenko VG; Caetano FA; Guimaraes AL; Ferretti GD; Daude N; Bertram L; Nogueira KO; Silva JL; Westaway D; Cashman NR; Martins VR; Prado VF; Prado MA
    J Biol Chem; 2016 Oct; 291(42):21945-21955. PubMed ID: 27563063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.